Latest Cancer immunotherapy Stories
Curadev's dual IDO and TDO immune tolerance inhibitor - a novel approach in cancer immunotherapy NEW DELHI, India, April 20, 2015 /PRNewswire/ -- Curadev Pharma
--Phase 3 Trial to Begin Enrolling Patients Later This Year-- SAN FRANCISCO, April 16, 2015 /PRNewswire/ -- SillaJen, Inc., a private clinical-stage biotherapeutics company focused
NW Bio Currently Ranked 8th Among the 25 Companies BETHESDA, Md., April 16, 2015 /PRNewswire/ -- Northwest Biotherapeutics, Inc.
SEATTLE, April 15, 2015 /PRNewswire/ -- Adaptive Biotechnologies, the company pioneering Next Generation Sequencing (NGS) applications for cancer immunology, and its collaborators will present
DALLAS, April 10, 2015 /PRNewswire/ -- Lifescienceindustryresearch.com adds Global & USA Cancer Immunotherapy Market Analysis to 2020 a new research report in its store.
NEW YORK and ANN ARBOR, Mich., April 8, 2015 /PRNewswire/ -- Lycera Corp., a biopharmaceutical company developing breakthrough
SAN DIEGO, April 6, 2015 /PRNewswire/ -- MabVax Therapeutics Holdings, Inc.
New research report “Global & USA Cancer Immunotherapy Market Analysis to 2020: Antibody Drug Conjugates (ADCs), Bispecific Monoclonal Antibodies, Cancer Vaccines, Cytokines, Interferons,
SEATTLE, March 30, 2015 /PRNewswire/ -- TapImmune Inc.
- The horn of a unicorn considered as a medical or pharmacological ingredient.
- A winged horse with a single horn on its head; a winged unicorn.